SOX2 and central nervous system cancer: Ikushima et al. showed that inhibition of TGF-beta signaling can significantly reduce the tumorigenesis of glioma initiating cells by promoting differentiation, and this effect attenuated in SOX2 transduced tumor initiating cells [13].